CRISPR-based RNA editing: diagnostic applications and therapeutic options

References

• Calin GA, Croce CM. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance. Semin Oncol. 2006 Apr;33(2):167–173. PubMed PMID: 16616063.
   PubMed Web of Science ®Google Scholar
• Munker R, Calin GA. MicroRNA profiling in cancer. Clin Sci. 2011 Aug;121(4):141–158. PubMed PMID: 21526983; eng.
   PubMed Web of Science ®Google Scholar
• Ling H, Vincent K, Pichler M, et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 2015 Sep 24;34(39):5003–5011. PubMed PMID: 25619839; PubMed Central PMCID: PMC4552604.
   PubMed Web of Science ®Google Scholar
• Mullin E 2017 Was the year of gene-therapy breakthroughs mit technology review 2018. [cited 2018 Aug 13]. Available from: https://www.technologyreview.com/s/609643/2017-was-the-year-of-gene-therapy-breakthroughs/
   Google Scholar
• Chira S, Gulei D, Hajitou A, et al. CRISPR/Cas9: transcending the reality of genome editing. Mol Ther Nucleic Acids. 2017 Jun 16;7:211–222. PubMed PMID: 28624197; PubMed Central PMCID: PMCPmc5415201. eng.
   PubMedGoogle Scholar
• Guha TK, Wai A, Hausner G. Programmable Genome editing tools and their regulation for efficient genome engineering. Comput Struct Biotechnol J. 2017;15:146–160. PubMed PMID: 28179977; PubMed Central PMCID: PMCPMC5279741.
   PubMed Web of Science ®Google Scholar
• Chira S, Gulei D, Hajitou A, et al. Restoring the p53 ‘guardian’ phenotype in p53-deficient tumor cells with CRISPR/Cas9. Trends Biotechnol. 2018 Jul;36(7):653–660. PubMed PMID: 29478674.
   PubMed Web of Science ®Google Scholar
• Gulei D, Berindan-Neagoe I. CRISPR/Cas9: a potential life-saving tool. What’s next? Mol Ther Nucleic Acids. 2017 Dec 15;9:333–336.
   PubMedGoogle Scholar
• Ribeil JA, Hacein-Bey-Abina S, Payen E, et al. Gene therapy in a patient with sickle cell disease. N Engl J Med. 2017 Mar 2;376(9):848–855. PubMed PMID: 28249145.
   PubMed Web of Science ®Google Scholar
• Zheng PP, Kros JM, Li J. Approved CAR T cell therapies: ice bucket challenges on glaring safety risks and long-term impacts. Drug Discov Today. 2018 Jun;23(6):1175–1182. PubMed PMID: 29501911.
   PubMed Web of Science ®Google Scholar
• Hirsch T, Rothoeft T, Teig N, et al. Regeneration of the entire human epidermis using transgenic stem cells. Nature. 2017. 11/08/online 551: 327.https://www.nature.com/articles/nature24487#supplementary-information
   PubMed Web of Science ®Google Scholar
• FDA. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss U.S. Department of Health and Human Services2018 [ cited 2018]. [cited 2018 Aug 13]. Available from: https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm589467.htm
   Google Scholar
• Bennett J, Wellman J, Marshall KA, et al. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial. Lancet. 2016;388(10045):661–672.
   PubMed Web of Science ®Google Scholar
• Leisegang M, Engels B, Schreiber K, et al. Eradication of large solid tumors by gene therapy with a t-cell receptor targeting a single cancer-specific point mutation. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Jun 1;22(11):2734–2743. PubMed PMID: 26667491; PubMed Central PMCID: PMC4891260.
   PubMed Web of Science ®Google Scholar
• Ferec C, Audrezet MP, Mercier B, et al. Detection of over 98% cystic fibrosis mutations in a Celtic population. Nat Genet. 1992 Jun;1(3):188–191. PubMed PMID: 1284639.
   PubMed Web of Science ®Google Scholar
• Higuchi M, Kazazian HH Jr., Kasch L, et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7405–7409. PubMed PMID: 1908096; PubMed Central PMCID: PMC52304.
   PubMed Web of Science ®Google Scholar
• Bolscher BG, de Boer M, de Klein A, et al. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood. 1991 Jun 1;77(11):2482–2487. PubMed PMID: 1710153.
   PubMed Web of Science ®Google Scholar
• Rees HA, Liu DR. Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet. 2018 Dec;19(12):770–788. PubMed PMID: 30323312; eng.
   PubMed Web of Science ®Google Scholar
• Maas S, Rich A. Changing genetic information through RNA editing. Biol Sci Nat Sci. 2000 Sep;22(9):790–802. PubMed PMID: 10944581.
   Google Scholar
• Kim H, Kim JS. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 2014 May;15(5):321–334. PubMed PMID: 24690881.
   PubMed Web of Science ®Google Scholar
• Nishikura K. Functions and regulation of RNA editing by ADAR deaminases. Annu Rev Biochem. 2010;79:321–349. PubMed PMID: 20192758; PubMed Central PMCID: PMC2953425.
   PubMed Web of Science ®Google Scholar
• Nishikura K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 2016 Feb;17(2):83–96. PubMed PMID: 26648264; PubMed Central PMCID: PMC4824625.
   PubMed Web of Science ®Google Scholar
• Slotkin W, Nishikura K. Adenosine-to-inosine RNA editing and human disease. PubMed PMID: 24289319; PubMed Central PMCID: PMC3979043 Genome Med. 2013;511:105.
   PubMedGoogle Scholar
• Rosenberg BR, Hamilton CE, Mwangi MM, et al. Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3ʹ UTRs. Nat Struct Mol Biol. 2011 Feb;18(2):230–236. PubMed PMID: 21258325; PubMed Central PMCID: PMC3075553.
   PubMed Web of Science ®Google Scholar
• Blow MJ, Grocock RJ, van Dongen S, et al. RNA editing of human microRNAs. Genome Biol. 2006;7(4):R27. PubMed PMID: 16594986; PubMed Central PMCID: PMC1557993.
   PubMed Web of Science ®Google Scholar
• Kawahara Y, Zinshteyn B, Sethupathy P, et al. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs. Science. 2007 Feb 23;315(5815):1137–1140. PubMed PMID: 17322061; PubMed Central PMCID: PMC2953418.
   PubMed Web of Science ®Google Scholar
• Azad MTA, Bhakta S, Tsukahara T. Site-directed RNA editing by adenosine deaminase acting on RNA for correction of the genetic code in gene therapy [Original Article]. Gene Ther. 2017;24(779):779–786. 12/07/online https://www.nature.com/articles/gt201790#supplementary-information
   PubMedGoogle Scholar
• Shah MY, Ferracin M, Pileczki V, et al. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 Apr;28(4):432–447. PubMed PMID: 29567676; PubMed Central PMCID: PMC5880235.
   PubMed Web of Science ®Google Scholar
• Jinnah HA, De Gregorio L, Harris JC, et al. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. Mutat Res. 2000 Oct;463(3):309–326. PubMed PMID: 11018746.
   PubMed Web of Science ®Google Scholar
• Cox DBT, Gootenberg JS, Abudayyeh OO, et al. RNA editing with CRISPR-Cas13. Science. 2017 Nov 24;358(6366):1019–1027. PubMed PMID: 29070703; PubMed Central PMCID: PMC5793859.
   PubMed Web of Science ®Google Scholar
• Stafforst T, Schneider MF. An RNA-deaminase conjugate selectively repairs point mutations. Angew Chem Int Ed in Engl. 2012 Oct 29;51(44):11166–11169. PubMed PMID: 23038402; eng.
   PubMed Web of Science ®Google Scholar
• Vogel P, Moschref M, Li Q, et al. Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs. Nat Methods. 2018 Jul;15(7):535–538. PubMed PMID: 29967493; eng.
   PubMed Web of Science ®Google Scholar
• Montiel-Gonzalez MF, Vallecillo-Viejo I, Yudowski GA, et al. Correction of mutations within the cystic fibrosis transmembrane conductance regulator by site-directed RNA editing. Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18285–18290. PubMed PMID: 24108353; PubMed Central PMCID: PMCPmc3831439. eng.
   PubMed Web of Science ®Google Scholar
• Montiel-Gonzalez MF, Vallecillo-Viejo IC, Rosenthal JJ. An efficient system for selectively altering genetic information within mRNAs. Nucleic Acids Res. 2016 Dec 1;44(21):e157. PubMed PMID: 27557710; PubMed Central PMCID: PMCPmc5137428. eng.
   PubMed Web of Science ®Google Scholar
• Vogel P, Stafforst T. Critical review on engineering deaminases for site-directed RNA editing. Curr Opin Biotechnol. 2018 Sep 5;55:74–80. PubMed PMID: 30193161; eng. .
   PubMedGoogle Scholar
• Woolf TM, Chase JM, Stinchcomb DT. Toward the therapeutic editing of mutated RNA sequences. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8298–8302. PubMed PMID: 7545300; PubMed Central PMCID: PMCPmc41144. eng.
   PubMed Web of Science ®Google Scholar
• Wettengel J, Reautschnig P, Geisler S, et al. Harnessing human ADAR2 for RNA repair - Recoding a PINK1 mutation rescues mitophagy. Nucleic Acids Res. 2017 Mar 17;45(5):2797–2808. PubMed PMID: 27907896; PubMed Central PMCID: PMCPmc5389476. eng.
   PubMed Web of Science ®Google Scholar
• Heep M, Mach P, Reautschnig P, et al. Applying human ADAR1p110 and ADAR1p150 for site-directed RNA editing-G/C substitution stabilizes guideRNAs against editing. Genes. 2017 Jan 14;8(1). PubMed PMID: 28098820; PubMed Central PMCID: PMCPmc5295028. eng.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Umeno H, Nose K, et al. Construction of a guide-RNA for site-directed RNA mutagenesis utilising intracellular A-to-I RNA editing. Sci Rep. 2017 Feb 2;7:41478. PubMed PMID: 28148949; PubMed Central PMCID: PMCPmc5288656. eng.
   PubMed Web of Science ®Google Scholar
• Berindan-Neagoe I, Calin GA. Molecular pathways: microRNAs, cancer cells, and microenvironment. Clin Cancer Res off J Am Assoc Cancer Res. 2014 Dec 15;20(24):6247–6253. PubMed PMID: 25512634; PubMed Central PMCID: PMC4461223.
   PubMed Web of Science ®Google Scholar
• Redis RS, Berindan-Neagoe I, Pop VI, et al. Non-coding RNAs as theranostics in human cancers. J Cell Biochem. 2012 May;113(5):1451–1459. PubMed PMID: 22213511; PubMed Central PMCID: PMC3337365.
   PubMed Web of Science ®Google Scholar
• Bullock M, Silva A, Kanlikilicer-Unaldi P, et al. Exosomal non-coding RNAs: diagnostic, prognostic and therapeutic applications in cancer. Noncoding RNA. 2015;1(1):53. PubMed PMID.
   PubMedGoogle Scholar
• Van Roosbroeck K, Fanini F, Setoyama T, et al. Combining anti-miR-155 with chemotherapy for the treatment of lung cancers. Clin Cancer Res off J Am Assoc Cancer Res. 2016 Nov 30 PubMed PMID: 27903673. doi: 10.1158/1078-0432.CCR-16-1025.
   Google Scholar
• Gulei D, Magdo L, Jurj A, et al. The silent healer: miR-205-5p up-regulation inhibits epithelial to mesenchymal transition in colon cancer cells by indirectly up-regulating E-cadherin expression. Cell Death Dis. 2018 Jan 19;9(2):66. PubMed PMID: 29352232; PubMed Central PMCID: PMCPmc5833765. eng.
   PubMedGoogle Scholar
• Braicu C, Ga C, Berindan-Neagoe I. MicroRNAs and cancer therapy - from bystanders to major players. Curr Med Chem. 2013;20(29): 3561–3573. PubMed PMID: 23834177; eng.
   PubMed Web of Science ®Google Scholar
• Eastlack SC, Alahari SK. MicroRNA and breast cancer: understanding pathogenesis, improving management. Noncoding RNA. 2015 Apr 20;1(1):17–43. PubMed PMID: 29861413; PubMed Central PMCID: PMCPmc5932537. eng.
   PubMedGoogle Scholar
• Kocak DD, Gersbach CA. From CRISPR scissors to virus sensors. Nature. 2018 May;557(7704):168–169. 10.1038/d41586-018-04975-8. PubMed PMID: 29730672.
   PubMed Web of Science ®Google Scholar
• Chen JS, Ma E, Harrington LB, et al. CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science. 2018 Apr 27;360(6387):436–439. PubMed PMID: 29449511; eng.
   PubMed Web of Science ®Google Scholar
• Gootenberg JS, Abudayyeh OO, Kellner MJ, et al. Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science. 2018 Apr 27;360(6387):439–444. PubMed PMID: 29449508; PubMed Central PMCID: PMC5961727.
   PubMed Web of Science ®Google Scholar
• Myhrvold C, Freije CA, Gootenberg JS, et al. Field-deployable viral diagnostics using CRISPR-Cas13. Science. 2018 Apr 27;360(6387):444–448. PubMed PMID: 29700266.
   PubMed Web of Science ®Google Scholar